Peripheral neuropathy Board decisions

The Veteran's claim for an effective date prior to October 6, 2017, for the grant of service connection for right lower extremity peripheral neuropathy of the sciatic nerve is dismissed as moot due to the earlier established effective date in May 2005.,The Veteran's claim for an effective date prior to June 16, 2017, for left lower extremity radiculopathy and diabetic peripheral neuropathy of the sciatic nerve is granted with an effective date of May 16, 2005. The claim for an effective date prior to October 6, 2017, for left lower extremity peripheral neuropathy of the femoral nerve is also granted with an effective date of May 16, 2005.

The Veteran's low back disability appeal was withdrawn and dismissed.,Service connection for sleep apnea, secondary to service-connected insomnia, is granted.

The Board denied a disability rating greater than 20 percent for external popliteal neuropathy of the right foot, finding that the Veteran's condition manifested in no worse than moderate incomplete paralysis.

The Board has found that the Veteran's diabetes mellitus type II is service-connected due to herbicide exposure. However, his bilateral lower extremity neuropathy remains unclear and requires further examination.

The Veteran's service connection claims for Parkinson's disease, coronary artery disease with cardiac stent, diabetes mellitus type II, and peripheral neuropathy of the lower extremities were denied. An effective date earlier than August 5, 2022 for a 100% rating for insomnia disorder with alcohol use disorder was also denied.

The Board has remanded the Veteran's claims for bilateral hearing loss, a right shoulder muscle tear with neuropathy (secondary to service-connected lumbar spine strain), and compensation under 38 U.S.C. § 1151 due to duty-to-assist errors.

The Veteran's claim of service connection for a left foot condition and peripheral neuropathy is granted. The new evidence, including a VA medical examination in 2020, supports the finding that his current conditions are related to his active-duty service.

The Veteran's claims for earlier effective dates for service connection and TDIU/DEA are being remanded due to the assignment of new effective dates.,Effective dates have been granted for CRD, DM, and diabetic peripheral neuropathy of the bilateral lower extremities. The RO is instructed to assign appropriate initial ratings and adjudicate the remaining TDIU and DEA claims.

The Board denied service connection for right and left lower extremity neuropathy, finding no evidence of onset during active duty or related to herbicide exposure.

The Veteran's service-connected peripheral neuropathy has rendered him unable to secure or follow a substantially gainful occupation, leading to the grant of a TDIU.

The Board has determined that the claim for payment of non-VA ambulance transportation services provided on June 14, 2025 is remanded due to missing relevant documents. The Veteran will be notified and asked to provide any documentation he may have.

The Veteran's PTSD is rated at 70 percent, but no higher. The other conditions are granted with service connection based on in-service exposure.

The Veteran's initial rating for hypertension prior to October 16, 2024 was denied. From October 16, 2024 onwards, a higher than 10 percent rating for hypertension is also denied. The claim for TDIU has been denied.

The Board has granted service connection for peripheral neuropathy of the upper right, left extremities and lower limbs due to herbicide exposure during service. The Veteran's hypertension is rated at 10 percent throughout the appeal period.

The Board has found that the Veteran's neuropathy of the left upper extremity, ulnar nerve warrants a rating in excess of 20 percent. However, the claim for service connection for hypertension is remanded due to pre-decisional duty-to-assist errors.

The Veteran's appeal is being remanded due to the need for additional medical opinions regarding his service connection claims and potential in-service toxic exposures.

The Board has remanded the Veteran's claims for bilateral upper and lower extremity peripheral neuropathy due to a failure of the AOJ to schedule examinations as required by duty-to-assist regulations.

The Board has denied the Veteran's claims for ratings in excess of 10 percent for service-connected peripheral neuropathy, left and right lower extremities with sciatic nerve involvement.

The Veteran's claims for increased ratings for prostate cancer and peripheral neuropathy of the bilateral upper and lower extremities were denied as a matter of law due to his failure to report for scheduled VA examinations.

The Board has granted an earlier effective date of December 28, 2017 for the grant of a 40 percent rating for peripheral neuropathy with involvement of the sciatic nerve in both lower extremities associated with diabetes type II.